Searched for
MYLAN BIOCON STAKE
CCI approves BC Asia Investments' stake acquisition in IIFL Wealth ManagementBC Asia Investments X Ltd is indirectly held by Bain Capital Investors LLC (Bain Private Equity), Bain Capital Credit Member LLC and Bain C...14 Jun, 2022, 09.21 PM IST- Viatris deal pinches Biocon, but may prove a good betThe $3.3-billion acquisition - that includes $2.3 billion cash and a 12.9% equity stake in BBL - stands at over half of the market cap of B...01 Mar, 2022, 10.05 AM IST
- Biocon arm to buy US company Biosimilar biz for $3.34 billionBiocon Biologics (BBL) will get the global biosimilar business of Viatris in developed and emerging markets, with an estimated revenue of $...01 Mar, 2022, 01.10 AM IST
- Biocon Biologics acquires Viatris' biosimilar business for $3.34 billionBBL said the cash payment of $2 billion to be funded by $800 million raised through equity infusion in BBL and the remainder to be funded b...28 Feb, 2022, 07.50 AM IST
- Buy Biocon, target price Rs 498: Centrum BrokingBiocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 49554.00 Crore) operating in Pharmaceuticals ...28 Oct, 2020, 10.52 AM IST
- Biocon shares gain 1% in early sessionShares of Biocon Ltd. traded 1.01 per cent up in trade at 11:03AM on Wednesday .15 Apr, 2020, 11.08 AM IST
- True North to acquire 2.4% stake in Biocon BiologicsDeal values Biocon Biologics at $3 billion06 Jan, 2020, 07.51 PM IST
- True North buys into Biocon Biologics, deal values firm at around $3.5 billionTrue North has acquired about 3 per cent of Biocon Biologics India Ltd (BBIL), a wholly owned subsidiary of Biocon, for $100 million, valui...06 Jan, 2020, 08.59 AM IST
- Temasek, TrueNorth-CPPIB seek to invest in Biocon BiologicsEye minority stake in Biocon Biologics; unit may be valued at $4 billion, higher than the market cap of Biocon.21 Aug, 2019, 07.03 PM IST
- Top stocks in focus on 10 October 2017Here is a list of top stocks that are likely to be in focus in today's trading session.10 Oct, 2017, 09.54 AM IST
- Biocon surges on USFDA's cancer drug approvalFor the quarter ended March 31, 2017, Biocon reported total revenue at Rs 632.10 crore and net profit stood at 203.80 crore.14 Jul, 2017, 04.11 PM IST
- Roche’s reputation at stake if Avastin biosimilar approved without trial: Kapil SibalThe judge asked the company to submit a compilation of judgments highlighting the protection given to drug innovators to support its call.21 May, 2016, 01.14 PM IST
- Biocon sets Syngene IPO price band at Rs 240-250Biocon plans to raise Rs 550 crore by diluting 11% stake in Syngene through the Initial Public Offer. The proceeds will mostly go into fund...17 Jul, 2015, 08.27 PM IST
- Syngene IPO money to fund Biocon research: ShawShaw said that Biocon has the largest biosimilar pipeline globally in phase three clinical trials and the IPO will help fund those costs.27 Jun, 2015, 01.09 PM IST
- Mylan may buy contraceptive co Famy Care for Rs 3,000 croreMylan is said to have pipped private equity bids from Bain Capital and Advent to move closer to a deal. Hong Kong-based AIF Capital holds 1...21 Jan, 2015, 01.33 PM IST
- Biocon's Q3 net profit dips by 15.78% to Rs 84.85 croreThe Bangalore-based firm gave up 70% of its stake in Axicorp last April for a consideration of 40 million euros to the original promoters.25 Jan, 2012, 03.27 PM IST
- M&As help small pharma cos make it bigConcord Biotech, a small Ahmedabad-based biotechnology firm, on Tuesday shipped its first consignment to its new $1.2bn US-based parent, My...08 Nov, 2006, 01.47 AM IST
Load More
